OEC Q1 2026 Earnings Significant EPS Miss Amid Positive Stock Reaction CUE Q3 2025 Earnings Narrower Loss Drives Positive Market Response Post Holdings Q1 2026 Earnings Strong EPS Beat Masks Mixed Underlying Performance Crescent Biopharma Inc CBIO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline KROS Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Amid Pipeline Progress CRVS Q1 2026 Earnings EPS Slightly Misses Estimates Amid Continued Clinical Development